India Glycols Share Price Today (INDIAGLYCO)
TODAY IN ONE LINE
INDIAGLYCO fell 1.3% on average volume, in line with Nifty's -0.4% move.
With a market cap of ₹7,756.67 Cr., it trades at a P/E of 26.54. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
India Glycols flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 31.9% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 13.1% and Profit up 35.7%
- ●Healthy Operating MarginsOPM is structurally strong at 15.4%
- ●High Promoter HoldingPromoters hold 59.6% skin-in-the-game
- ●Steady Dividend YieldReliable 1.08% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.01x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest India Glycols News
What changed recently?
Recent events, corporate actions, and announcements.
India Glycols Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for India Glycols Limited, framed against the sector median so the premium or discount is obvious at a glance.
India Glycols Limited trades at a P/E of 26.54× and P/B of 2.65×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
India Glycols Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for India Glycols Limited — derived from the live tape, not yesterday's close.
India Glycols Limited last traded at ₹1,157.8 with an intraday range of ₹1,142.05–₹1,175.3 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1157.80| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1241.22 | +83.42 | +7.20% |
| R3 | 1207.97 | +50.17 | +4.33% |
| R2 | 1191.63 | +33.83 | +2.92% |
| R1 | 1174.72 | +16.92 | +1.46% |
| PIVOT | 1158.38 | 0.58 | 0.05% |
| CURRENT | 1157.80 | — | — |
| S1 | 1141.47 | -16.33 | -1.41% |
| S2 | 1125.13 | -32.67 | -2.82% |
| S3 | 1108.22 | -49.58 | -4.28% |
| S4 | 1074.97 | -82.83 | -7.15% |
INDIAGLYCO is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹1157.6–₹1175.3
Trading Inside opening range
India Glycols Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for India Glycols Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
India Glycols Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹7,756.67 Cr. and reported EPS of ₹45.93.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 9,039 | 9,827 ▲ 8.7% |
| Sales Growth YoY %Derived | 14.11% | 8.71% |
| Other Income | 15 | 5 ▼ 66.1% |
| Total Income | 9,054 | 9,832 ▲ 8.6% |
| 2,408 | 2,662 ▲ 10.6% | |
| Gross ProfitDerived | 6,631 | 7,165 ▲ 8.0% |
| Gross Margin %Derived | 73.36% | 72.91% |
| 6,120 | 6,515 ▲ 6.5% | |
| EBITDA (Operating Profit)Derived | 511 | 649 ▲ 27.1% |
| OPM %Derived | 5.65% | 6.61% |
| 280 | 322 ▲ 15.1% | |
| Profit Before Tax (PBT) | 246 | 331 ▲ 34.5% |
| 61 | 84 ▲ 37.5% | |
| Effective Tax %Derived | 24.97% | 25.53% |
| Profit/Loss from Discontinued Ops | — | — |
| Total Profit for Period | 231 | 293 ▲ 26.8% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | 231 | 293 ▲ 26.8% |
| Net Profit Margin %Derived | 2.55% | 2.98% |
| PAT Growth YoY %Derived | 33.49% | 26.78% |
| Earnings Per Share (EPS ₹) | 37.29 | 43.68 ▲ 17.1% |
| Diluted Shares Outstanding (Cr) | 6 | 7 ▲ 8.2% |
| Share of Profit from Associates/JVs | 46 | 46 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -1 | -2 ▼ 24.6% |
| Total Expenses (incl. D&A & Interest) | 8,808 | 9,501 ▲ 7.9% |
| Material Cost % of RevenueDerived | 25.95% | 24.55% |
| Employee Cost % of RevenueDerived | 1.36% | 1.35% |
| Other Cost % of RevenueDerived | 66.35% | 64.95% |
| Interest Coverage (x)Derived | 2.41x | 2.95x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 4,162 | 5,117 ▲ 23.0% | 5,973 ▲ 16.7% | 5,427 ▼ 9.1% | 6,601 ▲ 21.6% | 6,642 ▲ 0.6% | 7,922 ▲ 19.3% | 9,039 ▲ 14.1% | 9,827 ▲ 8.7% | |
| Sales Growth YoY %Derived | — | 22.96% | 16.71% | -9.13% | 21.63% | 0.61% | 19.27% | 14.11% | 8.71% | |
| Other Income | 23 | 17 ▼ 26.9% | 9 ▼ 48.1% | 15 ▲ 74.0% | 22 ▲ 41.2% | 24 ▲ 10.9% | 26 ▲ 7.7% | 15 ▼ 43.5% | 5 ▼ 66.1% | |
| Total Income | 4,185 | 5,134 ▲ 22.7% | 5,981 ▲ 16.5% | 5,443 ▼ 9.0% | 6,623 ▲ 21.7% | 6,666 ▲ 0.6% | 7,947 ▲ 19.2% | 9,054 ▲ 13.9% | 9,832 ▲ 8.6% | |
2,003 | 2,073 ▲ 3.5% | 2,328 ▲ 12.3% | 1,499 ▼ 35.6% | 1,921 ▲ 28.2% | 1,582 ▼ 17.6% | 2,149 ▲ 35.8% | 2,408 ▲ 12.1% | 2,662 ▲ 10.6% | ||
| Gross ProfitDerived | 2,159 | 3,045 ▲ 41.1% | 3,644 ▲ 19.7% | 3,928 ▲ 7.8% | 4,680 ▲ 19.1% | 5,059 ▲ 8.1% | 5,773 ▲ 14.1% | 6,631 ▲ 14.9% | 7,165 ▲ 8.0% | |
| Gross Margin %Derived | 51.87% | 59.50% | 61.02% | 72.38% | 70.89% | 76.18% | 72.87% | 73.36% | 72.91% | |
1,835 | 2,628 ▲ 43.2% | 3,253 ▲ 23.8% | 3,660 ▲ 12.5% | 4,425 ▲ 20.9% | 4,764 ▲ 7.7% | 5,370 ▲ 12.7% | 6,120 ▲ 14.0% | 6,515 ▲ 6.5% | ||
| EBITDA (Operating Profit)Derived | 324 | 417 ▲ 28.9% | 392 ▼ 6.0% | 268 ▼ 31.6% | 255 ▼ 4.8% | 296 ▲ 15.8% | 402 ▲ 36.1% | 511 ▲ 27.0% | 649 ▲ 27.1% | |
| OPM %Derived | 7.77% | 8.15% | 6.56% | 4.94% | 3.87% | 4.45% | 5.08% | 5.65% | 6.61% | |
198 | 220 ▲ 10.8% | 226 ▲ 3.0% | 164 ▼ 27.8% | 371 ▲ 127.1% | 222 ▼ 40.2% | 221 ▼ 0.3% | 280 ▲ 26.3% | 322 ▲ 15.1% | ||
| Profit Before Tax (PBT) | 148 | 214 ▲ 44.2% | 174 ▼ 18.6% | 120 ▼ 31.3% | 348 ▲ 190.7% | 154 ▼ 55.9% | 207 ▲ 34.5% | 246 ▲ 19.0% | 331 ▲ 34.5% | |
51 | 81 ▲ 59.0% | 59 ▼ 26.4% | 11 ▼ 81.0% | 39 ▲ 249.6% | 24 ▼ 39.2% | 50 ▲ 110.0% | 61 ▲ 22.0% | 84 ▲ 37.5% | ||
| Effective Tax %Derived | 34.11% | 37.61% | 33.99% | 9.42% | 11.33% | 15.60% | 24.35% | 24.97% | 25.53% | |
| Profit/Loss from Discontinued Ops | — | — | — | 22 | 10 ▼ 54.2% | — ▼ 100.0% | — | — | — | |
| Total Profit for Period | 97 | 133 ▲ 37.4% | 115 ▼ 13.5% | 132 ▲ 14.8% | 340 ▲ 158.2% | 141 ▼ 58.5% | 173 ▲ 22.7% | 231 ▲ 33.5% | 293 ▲ 26.8% | |
| Less: Non-controlling Interests | — | — | — | — | — | 16 | — ▼ 100.0% | — | — | |
| Net Profit (Owner's PAT)Derived | 97 | 133 ▲ 37.4% | 115 ▼ 13.5% | 132 ▲ 14.8% | 340 ▲ 158.2% | 125 ▼ 63.2% | 173 ▲ 38.3% | 231 ▲ 33.5% | 293 ▲ 26.8% | |
| Net Profit Margin %Derived | 2.32% | 2.59% | 1.92% | 2.42% | 5.15% | 1.88% | 2.18% | 2.55% | 2.98% | |
| PAT Growth YoY %Derived | — | 37.38% | -13.54% | 14.78% | 158.23% | -63.20% | 38.30% | 33.49% | 26.78% | |
| Earnings Per Share (EPS ₹) | 15.59 | 21.38 ▲ 37.1% | 18.52 ▼ 13.4% | 21.25 ▲ 14.7% | 54.88 ▲ 158.3% | 20.20 ▼ 63.2% | 27.94 ▲ 38.3% | 37.29 ▲ 33.5% | 43.68 ▲ 17.1% | |
| Diluted Shares Outstanding (Cr) | 6 | 6 ▲ 0.0% | 6 ▲ 0.0% | 6 ▲ 0.0% | 6 ▲ 0.0% | 6 ▲ 0.0% | 6 ▲ 0.0% | 6 ▲ 0.0% | 7 ▲ 8.2% | |
| Share of Profit from Associates/JVs | -1 | -1 ▲ 23.2% | -0 ▲ 57.3% | 1 ▲ 275.6% | 21 ▲ 2800.0% | 11 ▼ 45.5% | 17 ▲ 46.5% | 46 ▲ 178.5% | 46 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | -0 ▼ 2100.0% | -1 ▼ 580.0% | 3 ▲ 324.3% | -0 ▼ 115.4% | 0 ▲ 185.1% | -0 ▼ 147.5% | -1 ▼ 584.2% | -2 ▼ 24.6% | |
| Total Expenses (incl. D&A & Interest) | 4,037 | 4,920 ▲ 21.9% | 5,807 ▲ 18.0% | 5,323 ▼ 8.3% | 6,275 ▲ 17.9% | 6,512 ▲ 3.8% | 7,741 ▲ 18.9% | 8,808 ▲ 13.8% | 9,501 ▲ 7.9% | |
| Material Cost % of RevenueDerived | 34.43% | 30.29% | 28.22% | 21.84% | 25.25% | 21.75% | 22.96% | 25.95% | 24.55% | |
| Employee Cost % of RevenueDerived | 2.33% | 1.97% | 1.92% | 1.54% | 1.35% | 1.34% | 1.30% | 1.36% | 1.35% | |
| Other Cost % of RevenueDerived | 41.76% | 49.38% | 52.54% | 65.90% | 65.68% | 70.39% | 66.49% | 66.35% | 64.95% | |
| Interest Coverage (x)Derived | 2.00x | 2.37x | 2.15x | 2.25x | 2.51x | 2.02x | 2.50x | 2.41x | 2.95x |
India Glycols segment analysis : revenue and profit mix.
Disclosed business segments at India Glycols with their share of revenue and profit, switchable between consolidated and standalone reporting.
India Glycols discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for India Glycols Limited.
Our AI distills the core fundamental drivers supporting India Glycols Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
India Glycols Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong promoter holding 59.63% signals management confidence and long-term commitment
Latest quarterly EPS grew 35.7% YoY; TTM EPS growth 31.9% reflects robust earnings momentum
Operating margin 11.73% demonstrates solid pricing power and cost control capabilities
Debt-to-equity 0.58x maintains moderate leverage, supporting strategic financial flexibility
Diversified portfolio across chemicals, spirits, and biopharma reduces sector concentration risk
Key Risks.
Latest quarterly EPS declined 12.6% sequentially despite YoY growth strength
Negative free cash flow in FY2025 and FY2024 raises liquidity and capital allocation concerns
Beta 1.39 indicates higher volatility than market, amplifying downside risk exposure
ROE 11.30% and ROCE 12.40% lag peer benchmarks, signaling capital inefficiency
Limited institutional ownership 3.52% reduces external oversight and market credibility
Flip Conditions.
Valuation risk. a P/E above 35 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.08. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
India Glycols Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — India Glycols Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
India Glycols Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for India Glycols Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
India Glycols Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for India Glycols Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in India Glycols Limited stood at 42.6% of traded volume, against a 20-day average of 47.4%.
India Glycols announcements: results, concalls, ratings, M&A.
Filings India Glycols sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
India Glycols files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 143 documents below.
Copy of Newspaper Publication
India Glycols Limited has informed the Exchange about Copy of Newspaper Publication
Updates
India Glycols Limited has informed the Exchange regarding 'Intimation of web-link of the Annual Report for FY 2025-26'.
Shareholders meeting
India Glycols Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 19, 2026
Copy of Newspaper Publication
India Glycols Limited has informed the Exchange about Copy of Newspaper Publication
Updates
India Glycols Limited has informed the Exchange regarding 'Intimation of 42nd Annual General Meeting'.
Investor decks & rating reports.
India Glycols dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue India Glycols has declared, sequenced by announce and record date.
India Glycols corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About India Glycols Limited: business, sector, key facts.
What India Glycols Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
India Glycols Limited operates in the Breweries & Distilleries industry under the Fast Moving Consumer Goods sector, listed as NSE: INDIAGLYCO, BSE: 500201.
India Glycols Limited (IGL) is an Indian green petrochemical company primarily involved in the manufacturing and sale of a diverse range of industrial chemicals. Their business operations are segmented into three key areas: Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. This diversified approach allows them to cater to a wide array of industrial and consumer needs.
The Bio-based Specialities and Performance Chemicals segment forms a significant portion of IGL's business. Here, they produce and market a broad spectrum of products, including various glycols (mono, di, and tri ethylene glycols), glycol ethers and acetates used in brake fluids, bio-polymers derived from guar and natural gums, and a selection of specialty chemicals. These specialty chemicals encompass a wide range of applications, from plasticisers and oil field chemicals to bio-amines, methyl soyate, MDEA and its derivatives, bio-potash granules, and their proprietary C-Smart specialty products. This segment highlights IGL's commitment to sustainable and bio-based alternatives within the chemical industry.
IGL's Potable Spirits segment focuses on the production and distribution of alcoholic beverages. Their brand portfolio includes a variety of whiskeys (Soulmate Blu and Single Reserve), vodka (Amazing), rum (Zumba and Beach House XXX), and economy spirits (Bunty), along with branded country liquor. This segment demonstrates IGL's expansion into the consumer goods market, leveraging their production capabilities to offer a selection of alcoholic drinks.
Finally, the Ennature Biopharma segment caters to the pharmaceutical and healthcare sectors. IGL produces natural active pharmaceutical ingredients (APIs), nutraceuticals, standardized botanical extracts, and nicotine derivatives. This segment underscores IGL's commitment to providing high-quality ingredients for the healthcare industry, complementing their offerings in other sectors.
In summary, India Glycols Limited operates across multiple sectors, showcasing a diversified business model. Their products find application in a vast array of industries including pharmaceuticals, textiles, automotive, personal care, industrial manufacturing, paints and coatings, oil and gas, food ingredients, packaging, and the spirits industry. Furthermore, IGL actively participates in the export market, distributing their products internationally.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Allied Blenders and Distillers (ABDL) Share PricePeer
- Associated Alcohols & Breweries (ASALCBR) Share PricePeer
- Bcl Industries (BCLIND) Share PricePeer
- Globus Spirits (GLOBUSSPR) Share PricePeer
- GM Breweries (GMBREW) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about India Glycols Limited (INDIAGLYCO).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of India Glycols Limited (INDIAGLYCO)?
The current share price of India Glycols Limited (INDIAGLYCO) is ₹1,157.8. Today, the stock has declined by ₹15.50 (1.32%), trading in a range of ₹1,142.05 to ₹1,175.3. The stock opened at ₹1,162 with a trading volume of 83,732 shares.
02Is India Glycols Limited stock a good investment for long-term?
India Glycols Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹7,756.67 crores, P/E ratio of 26.54, ROE of 11.30%, and ROCE of 12.40%. The dividend yield stands at 1.08%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of India Glycols Limited stock?
The 52-week high price of India Glycols Limited (INDIAGLYCO) is ₹1,835, while the 52-week low is ₹792.5. Currently trading at ₹1,157.8, the stock is 35.0% away from its 52-week low and 36.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy India Glycols Limited stock at the current price?
Whether to buy India Glycols Limited stock at ₹1,157.8 depends on multiple factors. The stock is currently trading with a P/E ratio of 26.54 and P/B ratio of 2.65. Today's performance shows a loss of 1.32%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of India Glycols Limited and when is the next dividend?
India Glycols Limited offers a dividend yield of 1.08%, which means for every ₹100 invested at the current price of ₹1,157.8, you can expect to receive approximately ₹1.08 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of India Glycols Limited?
India Glycols Limited's key financial metrics include: P/E Ratio: 26.54, P/B Ratio: 2.65, ROE: 11.30%, ROCE: 12.40%, Dividend Yield: 1.08%, EPS: ₹45.93, Book Value: ₹437.6, and Debt-to-Equity: 0.58. The company's market cap stands at ₹7,756.67 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is India Glycols Limited stock performing today in the market?
India Glycols Limited stock opened at ₹1,162 and is currently trading at ₹1,157.8, showing a decline of ₹15.50 (1.32%). The intraday high is ₹1,175.3 and low is ₹1,142.05. The trading volume stands at 83,732 shares, indicating moderate market participation today.
08What is the P/E ratio of India Glycols Limited and what does it indicate?
India Glycols Limited has a Price-to-Earnings (P/E) ratio of 26.54, which means investors are willing to pay ₹26.54 for every ₹1 of earnings. With an EPS of ₹45.93, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about India Glycols Limited (INDIAGLYCO) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.